Oxaliplatin-Induced Hyperammonemic Encephalopathy in a Patient with Metastatic Pancreatic Cancer: A Case Report

Oxaliplatin-Induced Hyperammonemic Encephalopathy in a Patient with Metastatic Pancreatic Cancer: A Case Report

Oxaliplatin-based chemotherapy is widely used to treat advanced cancer. Oxaliplatin-induced hyperammonemic encephalopathy is rarely reported. Here, we report a case of oxaliplatin-induced hyperammonemic encephalopathy occurring after gemcitabine plus oxaliplatin (GEMOX) chemotherapy in a patient wit...

Full description

Bibliographic Details
Main Authors: Takatsugu Ogata, Hironaga Satake, Misato Ogata, Yukimasa Hatachi, Hisateru Yasui
Format: Article
Language:English
Published: Karger Publishers 2017-10-01
Series:Case Reports in Oncology
Subjects:
Hyperammonemia
Oxaliplatin
GEMOX
Pancreatic cancer
Urea cycle
Hyperammonemic encephalopathy
Online Access:https://www.karger.com/Article/FullText/481398

Internet

https://www.karger.com/Article/FullText/481398

Similar Items